CLINICAL_TRIALS ClinicalTrials.gov record update

VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03110770
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:40:00.072743+00:00
Published At: 2020-12-04T00:00:00+00:00
Record Updated At: 2024-01-31
Results Posted At: 2020-12-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Zika Virus", "Zika Virus Infection", "Virus Diseases", "Flavivirus Infections", "Flaviviral Diseases", "Flaviviridae Infections", "RNA Virus Infections"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-01-31"
protocolSection.identificationModule.nctId: "NCT03110770"
protocolSection.identificationModule.officialTitle: "VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-12-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.